-
1
-
-
28244466312
-
A clinical and molecular overview of the human osteopetroses
-
DOI 10.1007/s00223-005-0027-6
-
W Balemans L Van Wesenbeeck W Van Hul 2005 A clinical and molecular overview of the human osteopetroses Calcif Tissue Int 77 263 274 10.1007/s00223-005-0027-6 1:CAS:528:DC%2BD2MXht1GisLfE 16307387 (Pubitemid 41704904)
-
(2005)
Calcified Tissue International
, vol.77
, Issue.5
, pp. 263-274
-
-
Balemans, W.1
Van Wesenbeeck, L.2
Van Hul, W.3
-
3
-
-
33645789497
-
Clinical, genetic, and cellular analysis of 49 osteopetrotic patients: Implications for diagnosis and treatment
-
10.1136/jmg.2005.036673 1:CAS:528:DC%2BD28XktlymtLs%3D 16118345
-
A Del Fattore B Peruzzi N Rucci I Recchia A Cappariello M Longo, et al. 2006 Clinical, genetic, and cellular analysis of 49 osteopetrotic patients: implications for diagnosis and treatment J Med Genet 43 315 325 10.1136/jmg.2005.036673 1:CAS:528:DC%2BD28XktlymtLs%3D 16118345
-
(2006)
J Med Genet
, vol.43
, pp. 315-325
-
-
Del Fattore, A.1
Peruzzi, B.2
Rucci, N.3
Recchia, I.4
Cappariello, A.5
Longo, M.6
-
4
-
-
0038011833
-
Evolving concepts of rheumatoid arthritis
-
DOI 10.1038/nature01661
-
GS Firestein 2003 Evolving concepts of rheumatoid arthritis Nature 423 356 361 10.1038/nature01661 1:CAS:528:DC%2BD3sXjs1ynu7c%3D 12748655 (Pubitemid 40852711)
-
(2003)
Nature
, vol.423
, Issue.6937
, pp. 356-361
-
-
Firestein, G.S.1
-
5
-
-
0036733711
-
Bone and joint destruction in rheumatoid arthritis: What is really happening?
-
1:CAS:528:DC%2BD38Xnslehtrk%3D 12236623
-
SR Goldring 2002 Bone and joint destruction in rheumatoid arthritis: what is really happening? J Rheumatol Suppl 65 44 48 1:CAS:528:DC%2BD38Xnslehtrk%3D 12236623
-
(2002)
J Rheumatol Suppl
, vol.65
, pp. 44-48
-
-
Goldring, S.R.1
-
6
-
-
0034121039
-
Involvement of receptor activator of nuclear factor κB ligand/osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritis
-
DOI 10.1002/1529-0131(200002)43:2<259::AID-ANR4>3.0.CO;2-W
-
H Takayanagi H Iizuka T Juji T Nakagawa A Yamamoto T Miyazaki, et al. 2000 Involvement of receptor activator of nuclear factor kappaB ligand/osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritis Arthritis Rheum 43 259 269 10.1002/1529-0131(200002)43: 2<259::AID-ANR4>3.0.CO;2-W 1:CAS:528:DC%2BD3cXhs1aqtLw%3D 10693864 (Pubitemid 30395733)
-
(2000)
Arthritis and Rheumatism
, vol.43
, Issue.2
, pp. 259-269
-
-
Takayanagi, H.1
Iizuka, H.2
Juji, T.3
Nakagawa, T.4
Yamamoto, A.5
Miyazaki, T.6
Koshihara, Y.7
Oda, H.8
Nakamura, K.9
Tanaka, S.10
-
7
-
-
0034122050
-
Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor
-
DOI 10.1002/1529-0131(200002)43:2<250::AID-ANR3>3.0.CO;2-P
-
EM Gravallese C Manning A Tsay A Naito C Pan E Amento, et al. 2000 Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor Arthritis Rheum 43 250 258 10.1002/1529-0131(200002)43: 2<250::AID-ANR3>3.0.CO;2-P 1:STN:280:DC%2BD3c7lsFGgsg%3D%3D 10693863 (Pubitemid 30395732)
-
(2000)
Arthritis and Rheumatism
, vol.43
, Issue.2
, pp. 250-258
-
-
Gravallese, E.M.1
Manning, C.2
Tsay, A.3
Naito, A.4
Pan, C.5
Amento, E.6
Goldring, S.R.7
-
8
-
-
0035153246
-
TRANCE/RANKL knockout mice are protected from bone erosion in a serum transfer model of arthritis
-
1:STN:280:DC%2BD3Mnltl2rsA%3D%3D 11696430
-
AR Pettit H Ji D von Stechow R Müller SR Goldring Y Choi, et al. 2001 TRANCE/RANKL knockout mice are protected from bone erosion in a serum transfer model of arthritis Am J Pathol 159 1689 1699 1:STN:280: DC%2BD3Mnltl2rsA%3D%3D 11696430
-
(2001)
Am J Pathol
, vol.159
, pp. 1689-1699
-
-
Pettit, A.R.1
Ji, H.2
Von Stechow, D.3
Müller, R.4
Goldring, S.R.5
Choi, Y.6
-
9
-
-
0036853902
-
Osteoclasts are essential for TNF-alpha-mediated joint destruction
-
1:CAS:528:DC%2BD38XovFOnu7s%3D 12438440
-
K Redlich S Hayer R Ricci JP David M Tohidast-Akrad G Kollias, et al. 2002 Osteoclasts are essential for TNF-alpha-mediated joint destruction J Clin Invest 110 1419 1427 1:CAS:528:DC%2BD38XovFOnu7s%3D 12438440
-
(2002)
J Clin Invest
, vol.110
, pp. 1419-1427
-
-
Redlich, K.1
Hayer, S.2
Ricci, R.3
David, J.P.4
Tohidast-Akrad, M.5
Kollias, G.6
-
10
-
-
3142741595
-
Zoledronic acid protects against local and systemic bone loss in tumor necrosis factor-mediated arthritis
-
DOI 10.1002/art.20384
-
P Herrak B Gortz S Hayer K Redlich E Reiter J Gasser, et al. 2004 Zoledronic acid protects against local and systemic bone loss in tumor necrosis factor-mediated arthritis Arthritis Rheum 50 2327 2337 10.1002/art.20384 1:CAS:528:DC%2BD2cXmsVantrs%3D 15248234 (Pubitemid 38924413)
-
(2004)
Arthritis and Rheumatism
, vol.50
, Issue.7
, pp. 2327-2337
-
-
Herrak, P.1
Gortz, B.2
Hayer, S.3
Redlich, K.4
Reiter, E.5
Gasser, J.6
Bergmeister, H.7
Kollias, G.8
Smolen, J.S.9
Schett, G.10
-
11
-
-
0033581952
-
Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand
-
10.1038/46303 1:CAS:528:DyaK1MXnvFShsLg%3D 10580503
-
YY Kong U Feige I Sarosi B Bolon A Tafuri S Morony, et al. 1999 Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand Nature 402 304 309 10.1038/46303 1:CAS:528: DyaK1MXnvFShsLg%3D 10580503
-
(1999)
Nature
, vol.402
, pp. 304-309
-
-
Kong, Y.Y.1
Feige, U.2
Sarosi, I.3
Bolon, B.4
Tafuri, A.5
Morony, S.6
-
12
-
-
3142763806
-
Targeting osteoclasts with zoledronic acid prevents bone destruction in collagen-induced arthritis
-
DOI 10.1002/art.20382
-
NA Sims JR Green M Glatt S Schlict TJ Martin MT Gillespie, et al. 2004 Targeting osteoclasts with zoledronic acid prevents bone destruction in collagen-induced arthritis Arthritis Rheum 50 2338 2346 10.1002/art.20382 1:CAS:528:DC%2BD2cXmsVantrg%3D 15248235 (Pubitemid 38924414)
-
(2004)
Arthritis and Rheumatism
, vol.50
, Issue.7
, pp. 2338-2346
-
-
Sims, N.A.1
Green, J.R.2
Glatt, M.3
Schlict, S.4
Martin, T.J.5
Gillespie, M.T.6
Romas, E.7
-
13
-
-
43949139580
-
Denosumab treatment effects on structural damage, bone mineral density, and bone turnover in rheumatoid arthritis: A twelve-month, multicenter, randomized, double-blind, placebo-controlled, phase II clinical trial
-
DOI 10.1002/art.23417
-
SB Cohen RK Dore NE Lane PA Ory CG Peterfy JT Sharp, et al. 2008 Denosumab treatment effects on structural damage, bone mineral density, and bone turnover in rheumatoid arthritis: a twelve-month, multicenter, randomized, double-blind, placebo-controlled, phase II clinical trial Arthritis Rheum 58 1299 1309 10.1002/art.23417 1:CAS:528:DC%2BD1cXms1ehu70%3D 18438830 (Pubitemid 351705919)
-
(2008)
Arthritis and Rheumatism
, vol.58
, Issue.5
, pp. 1299-1309
-
-
Cohen, S.B.1
Dore, R.K.2
Lane, N.E.3
Ory, P.A.4
Peterfy, C.G.5
Sharp, J.T.6
Van Der Heijde, D.7
Zhou, L.8
Tsuji, W.9
Newmark, R.10
|